Walleye Capital
MTACU

Walleye Capital’s MedTech Acquisition Corporation Unit MTACU Stock Holding History

Walleye Capital’s Portfolio MTACU Stock Details MTACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12,414
Closed -$124 – 1889
2021
Q2 		$124 Buy
12,414
+600
+5% +$6.07K ﹤0.01% 1141
2021
Q1 		$119 Sell
11,814
-186
-2% -$1.98K 0.01% 1008
2020
Q4 		$126 Buy
+12,000
New +$125K 0.01% 792

Other funds holding MTACU

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Walleye Capital's MTACU Position: Q3 2021 in Review

Walleye Capital sold out of MedTech Acquisition Corporation Unit (MTACU) in Q3 2021, closing a stake of 12,414 shares — an estimated $124 sold.

Walleye Capital first reported a position in MTACU in Q4 2020 and held it in 3 quarters. The position peaked at $126 in Q4 2020. 20 funds tracked by Wall St. Rank hold MTACU as of Q3 2021.

  • Walleye Capital reported no remaining MedTech Acquisition Corporation Unit position as of Q3 2021 after selling out during the quarter.
  • Walleye Capital sold 12,414 MedTech Acquisition Corporation Unit shares in Q3 2021, an estimated $124.
  • Walleye Capital first reported a position in MedTech Acquisition Corporation Unit in Q4 2020 and held it in 3 quarters.
  • Walleye Capital's MedTech Acquisition Corporation Unit position peaked at $126 in Q4 2020.
  • 20 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q3 2021.

Based on Walleye Capital's 13F filing for Q3 2021, filed 15 Nov 2021.